Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake

4 hours ago 5

Jonathan Ponciano, The Motley Fool

Mon, February 16, 2026 astatine 11:35 AM CST 4 min read

On February 12, 2026, Barington Companies Management disclosed a caller presumption successful Chemed (NYSE:CHE), acquiring 13,000 shares successful an estimated $5.56 cardinal trade.

According to an SEC filing dated February 12, 2026, Barington Companies Management established a caller presumption successful Chemed, acquiring 13,000 shares. The quarter-end worth of the involvement was $5.56 million.

This caller presumption accounts for 3.65% of Barington Companies Management’s reportable U.S. equity assets pursuing the filing.
Top 5 holdings aft the filing:
- NYSE: M: $28.66 cardinal (18.8% of AUM)
- NASDAQ: MATW: $26.12 cardinal (17.1% of AUM)
- NYSE: VSCO: $23.02 cardinal (15.1% of AUM)
- NYSE: BILL: $21.27 cardinal (14.0% of AUM)
- NYSE: GIL: $15.94 cardinal (10.5% of AUM)
As of February 12, 2026, shares of Chemed were priced astatine $463.95, down 15.18% implicit the anterior twelvemonth and trailing the S&P 500 by 28.09 percent points.

Metric

Value

Price (as of marketplace adjacent February 12, 2026)	$463.95
Market capitalization	$6.76 billion
Revenue (TTM)	$2.53 billion
Net income (TTM)	$278.81 million

Chemed operates done 2 main segments: VITAS, which provides hospice and palliative attraction services, and Roto-Rooter, offering plumbing, drain cleaning, and h2o restoration services.
The institution generates gross chiefly from healthcare services delivered to patients and from residential and commercialized plumbing and attraction solutions.
Its superior customers see patients and families successful request of end-of-life care, arsenic good arsenic residential and commercialized spot owners requiring plumbing and related services.

Chemed is simply a diversified services institution with a beardown beingness successful some the healthcare and indispensable location services markets. Its dual-segment exemplary enables unchangeable gross streams by serving captious needs successful hospice attraction and spot maintenance. The institution leverages its nationalist network, marque strength, and operational expertise to support a competitory presumption successful its halfway markets.

This determination matters due to the fact that it signals condemnation successful a steady, cash-rich relation that conscionable deed a unsmooth spot successful sentiment, but not successful solvency. Chemed generated $624.9 cardinal successful third-quarter revenue, up 3.1% twelvemonth implicit year, but adjusted diluted EPS came successful astatine $5.27, down 6.6% twelvemonth implicit year. GAAP EPS was harder-hit, falling 10.8% to $4.46, but that diminution came alongside continued gross maturation astatine VITAS and Roto-Rooter and ongoing stock repurchases.

VITAS gross climbed 4.2% to $407.7 million, with admissions up 5.6% and mean regular census up 2.5%. Roto-Rooter grew gross 1.1% to $217.2 million, though margins compressed. Importantly, Chemed ended the 4th with $129.8 cardinal successful currency and nary existent oregon semipermanent debt, and it reiterated full-year guidance of $22.00 to $22.30 per share.

Within a portfolio dominated by user and exertion names similar Macy’s, Victoria’s Secret, and BILL, this 3.65% presumption adds antiaircraft vulnerability successful the precise antithetic fields of hospice attraction and indispensable plumbing services. Ultimately, semipermanent investors should absorption connected currency generation, equilibrium expanse strength, and demographic tailwinds successful hospice, not a azygous quarter’s borderline pressure.

Read Entire Article